(+/-)-2-HYDROXYTRIDECANOICACID
(+/-)-2-HYDROXYTRIDECANOICACID structure
|
Common Name | (+/-)-2-HYDROXYTRIDECANOICACID | ||
|---|---|---|---|---|
| CAS Number | 100828-16-8 | Molecular Weight | 252.20 | |
| Density | 1.408g/cm3 | Boiling Point | 546.7ºC at 760mmHg | |
| Molecular Formula | C8H17N2O5P | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 284.4ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of (+/-)-2-HYDROXYTRIDECANOICACID(RS)-CPP ((±)-CPP) is a potent and selective NMDA antagonist. (RS)-CPP inhibits central neuron responses, and has anticonvulsant activity[1]. |
| Name | (RS)-3-(2-Carboxypiperazin-4-yl)-propyl-1-phosphonicacid |
|---|---|
| Synonym | More Synonyms |
| Description | (RS)-CPP ((±)-CPP) is a potent and selective NMDA antagonist. (RS)-CPP inhibits central neuron responses, and has anticonvulsant activity[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.408g/cm3 |
|---|---|
| Boiling Point | 546.7ºC at 760mmHg |
| Molecular Formula | C8H17N2O5P |
| Molecular Weight | 252.20 |
| Flash Point | 284.4ºC |
| Exact Mass | 252.08800 |
| PSA | 119.91000 |
| Vapour Pressure | 2.14E-13mmHg at 25°C |
| Index of Refraction | 1.53 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 22-26-36 |
| RIDADR | NONH for all modes of transport |
|
~76%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: Demaine; Smith Synthesis, 1992 , # 11 p. 1065 - 1067 |
|
~%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: British Technology Group Limited Patent: US5399693 A1, 1995 ; |
|
~%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: Demaine; Smith Synthesis, 1992 , # 11 p. 1065 - 1067 |
|
~75%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: Demaine; Smith Synthesis, 1992 , # 11 p. 1065 - 1067 |
|
~%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: Pevarello, P.; Scappi, G.; Varasi, M. Organic Preparations and Procedures International, 1994 , vol. 26, # 3 p. 366 - 370 |
|
~%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: Demaine; Smith Synthesis, 1992 , # 11 p. 1065 - 1067 |
|
~%
(+/-)-2-HYDROXY... CAS#:100828-16-8 |
| Literature: Pevarello, P.; Scappi, G.; Varasi, M. Organic Preparations and Procedures International, 1994 , vol. 26, # 3 p. 366 - 370 |
![(+/-)-tert-Butyl 4-[3-(diethoxyphosphinyl)propyl]piperazine-2-carboxylate structure](https://www.chemsrc.com/caspic/261/146398-95-0.png)
![(+/-)-Ethyl 4-[3-(diethoxyphosphinyl)propyl]piperazine-2-carboxylate structure](https://www.chemsrc.com/caspic/147/146398-98-3.png)
|
High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity.
Toxicol. In Vitro 29 , 1916-31, (2015) Testing hepatotoxicity is a crucial step in the development and toxicological assessment of drugs and chemicals. Bio-activation can lead to the formation of metabolites which may present toxicity for ... |
|
|
Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
PLoS ONE 9(11) , e112413, (2014) Parkinson disease (PD) is a multi-factorial neurodegenerative disorder with loss of dopaminergic neurons in the substantia nigra and characteristic intracellular inclusions, called Lewy bodies. Geneti... |
|
|
Regulation of AMPA receptor phosphorylation by the neuropeptide PACAP38.
Proc. Natl. Acad. Sci. U. S. A. 112 , 6712-7, (2015) Dynamic changes in synaptic strength are thought to be critical for higher brain function such as learning and memory. Alterations in synaptic strength can result from modulation of AMPA receptor (AMP... |
| 3-2-Cpp |
| DL-CPP |